ArticleInvestigational new drugs2023

Enhanced antitumor and anti-metastasis by VEGFR2-targeted doxorubicin immunoliposome synergy with NK cell activation.

Mingzhu Pan et al.PubMed ↗Publisher ↗

No numbers read from the abstract.